Latest News for: usfda

Edit

Alembic Pharma gets USFDA tentative nod for generic prostate cancer drug

The Times of India 14 May 2026
Alembic Pharmaceuticals has secured tentative approval from the ...
Edit

Alembic Pharma gets USFDA tentative approval for generic prostate cancer drug

Business Line 14 May 2026
Darolutamide 300 mg tablets ...
Edit

Caplin Steriles Gets USFDA Nod for Generic Calcium Gluconate Injection in Multiple Strengths

Chem Analyst 08 May 2026
Caplin Steriles Limited, a subsidiary of ...
Edit

Lupin Secures USFDA Approval for Oral Liquid Targeting Urea Cycle Disorders

Chem Analyst 06 May 2026
Global pharmaceutical company Lupin ...
Edit

Zydus Biologics’ Ahmedabad injectable facility gets 7 observations in USFDA inspection

The Times of India 06 May 2026
... in Ahmedabad underwent a USFDA inspection between April 27 and May 5, 2026.
Edit

Zydus Biologics’ Ahmedabad injectable facility gets 7 observations in USFDA inspection

The Economic Times 06 May 2026
... in Ahmedabad underwent a USFDA inspection between April 27 and May 5, 2026.
Edit

Indonesia-USFDA pact boosts $45 million spice trade security

Antara News 06 May 2026
Through the signing of the CC on April 15, 2026, BPOM and USFDA strengthened their collaboration in the exchange of non-public information ... Furthermore, BPOM and USFDA now both hold WHO-Listed Authority (WLA) status.
Edit

USFDA, DCA hold meet on best practices

The Times of India 05 May 2026
Comments. +Text SizeSmallMediumLarge. .
Edit

Cipla gets USFDA nod for generic respiratory issues treatment inhalation aerosol

The Times of India 23 Apr 2026
.
Edit

USFDA issues Form-483 with 5 observations to Ajanta Pharma's Paithan facility

The Times of India 22 Apr 2026
.
Edit

Lupin launches generic diabetes drug in US after USFDA approval

Business Line 22 Apr 2026
The tablets, available ...
Edit

Lupin receives Form 483 after USFDA inspection of Somerset unit

Business Line 18 Apr 2026
Lupin said it will address the ...
Edit

Morepen Secures Fourth Consecutive USFDA Inspection with Zero Observations (NIL 483) (Morepen Laboratories Ltd)

Public Technologies 17 Apr 2026
Successful completion of USFDA inspection of Masulkhana facility, Himachal Pradesh ... Morepen Secures Fourth Consecutive USFDA Inspection with Zero Observations (NIL 483).
Edit

Alembic Pharmaceuticals gets USFDA nod for generic cancer, arthritis treatment injection

Business Line 16 Apr 2026
The final approval granted is for ...
Edit

USFDA reconsiders peptide regulations, impacting wellness market

India Today 16 Apr 2026
USFDA reconsiders peptide regulations impacting wellness market ... .

Article Search

tools
×
×
×
×